Literature DB >> 21675898

Bevacizumab for retinopathy of prematurity.

Clare E Gilbert, Andrea Zin, Brian Darlow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21675898     DOI： 10.1056/NEJMc1103460

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?

Authors:  Andreas Stahl; Ann Hellstrom; Lois E H Smith
Journal:  Neonatology       Date:  2014-10-05       Impact factor: 4.035

2.  Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?

Authors:  Rajvardhan Azad; Vivek Dave; Subhadra Jalali
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

3.  SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.

Authors:  Melissa V R Gammons; Andrew D Dick; Steven J Harper; David O Bates
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-27       Impact factor: 4.799
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.